Medicare Market-Based Payment

Medicare’s Market-Based Payment System: Effects on Labs


On February 1st  at 2pm EST XIFIN’s CEO and Executive Chairman Lâle White will speak on a Laboratory Economics teleconference on the effects of Medicare’s new market-based payment system for labs.

The speakers on the panel will include the leader of the Health and Law Practice at Mintz Levin, Karen Lovitch, along with the President of Laboratory Billing Solutions, Thomas Hirsch and moderator, Dennis Weissman, President of Dennis Weissman & Associates, LLC.

This new system has created challenges and loopholes in the lab industry that need discussion. Some of the topics that will be covered are as follows:

Hospitals, physician offices and other independent labs are going to be absorbing 82% of the proposed cost reduction of this plan.
  • Review how Medicare payments for high volume, molecular and proprietary tests will change during 2018-2020
  • Identify which labs are the biggest winners & losers under Medicare’s revised CLFS
  • Find out the latest word from CMS on advanced diagnostic laboratory tests (ADLTs)
  • Understand how eliminating ATP payments will result in reimbursement hikes; “gaming” the system might cause compliance problems
  • Determine how uniform lab payment rates regardless of geography will work to the advantage of some states
  • Assess how Medicare’s market-based pricing affects Medicaid, Federal Employees Health Benefits, and private insurance payments
  • Obtain the latest status of ACLA’s lawsuit seeking HHS publish a rule that includes pricing data from all industry segments
  • Get answers to your specific questions about Medicare’s new lab payment approach

To reserve your spot for this Laboratory Economics hosted event, visit

Published by XIFIN
Share This Post:

Sign Up for Blog Alerts

Search Blog Posts

Blog Posts By Date